Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2010
11/04/2010WO2010071769A3 Chimeric l. monocytogens in1b protein
11/04/2010WO2010029363A3 Cathepsin s propeptide fragments
11/04/2010WO2010017403A9 Therapeutic compositions, devices and methods for observing treated tissues
11/04/2010US20100281566 Transcriptional control element, chimeric consructs and uses therefor
11/04/2010US20100280452 Medical devices having multiple layers
11/04/2010US20100280310 Laparoscopic Gastric Band With Active Agents
11/04/2010US20100280229 Polypeptide
11/04/2010US20100280222 Clostridial neurotoxin compositions and modified clostridial neurotoxins
11/04/2010US20100279959 Medium-Chain Length Fatty Acids, Glycerides and Analogues as Neutrophil Survival and Activation Factors
11/04/2010US20100279955 Novel lipid tripeptide-based hydrogelator and hydrogel
11/04/2010US20100279954 Method for treating celiac disease
11/04/2010US20100279953 Non-protein stabilized clostridial toxin pharmaceutical compositions
11/04/2010US20100279952 Cross-linked hydrogel containing an active substance
11/04/2010US20100279951 Method of treating allergic conjunctivitis with cyclosporin compositions
11/04/2010US20100279950 Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods
11/04/2010US20100279949 Process for preparing recombinant heterocarpine
11/04/2010US20100279948 EPIGENETIC MODIFICATIONS AT TNFalpha AS BIOMARKERS FOR SENSITIVITY TO SMAC MIMETIC-INDUCED APOPTOSIS
11/04/2010US20100279947 Modifications of apoptin
11/04/2010US20100279946 Use of an active principle from flax for use in a composition for activating cytochrome c
11/04/2010US20100279945 High-potency botulinum toxin formulations
11/04/2010US20100279944 Suppression and treatment of neuropathic pain
11/04/2010US20100279943 Cytoplasmic malate dehydrogenase (mdh1) targeted treatment for neurodegenerative diseases
11/04/2010US20100279942 Methods for treating motor neuron disease
11/04/2010US20100279941 Cd36 modulation and uses thereof
11/04/2010US20100279940 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof
11/04/2010US20100279939 Recombinant human fibrinogen for treatment of bleeding in trauma and platelet disorders
11/04/2010US20100279938 Platelet Promoting Protein and The Usage Thereof
11/04/2010US20100279937 Method of Inhibiting Angiogenesis, Tumorigenesis and Cathepsin Activity
11/04/2010US20100279936 Substituted acetylenic compounds useful for the treatment of diseases
11/04/2010US20100279935 Compositions for inducing labor and associated methods
11/04/2010US20100279934 Topical compositions for delivery of proteins and peptides
11/04/2010US20100279933 Vegf antagonist formulations
11/04/2010US20100279932 Binding constructs and methods for use thereof
11/04/2010US20100279931 Insulin Derivative
11/04/2010US20100279930 Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour
11/04/2010US20100279928 Sldlr in viral hepatitis
11/04/2010US20100279927 Growth factor complex
11/04/2010US20100279926 Compositions and Methods for Treating Atherosclerosis
11/04/2010US20100279925 Airway Administration of Site-Inactived FVIIA in Inflammatory Conditions Affecting the Respiratory Tract
11/04/2010US20100279924 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
11/04/2010US20100279923 Therapeutic application of kazal-type serine protease inhibitors
11/04/2010US20100279922 Melanocortin Receptor Ligands
11/04/2010US20100279921 Impaired wound healing compositions and treatments
11/04/2010US20100279920 Critical care product for neonatal calves
11/04/2010US20100279919 Compositions comprising human integrin-linked kinase-sirna and methods of use thereof
11/04/2010US20100279918 Chimeric Constructs Between Cancer-Homing Peptides and Cell-Penetrating Peptides Coupled to Anticancer Drugs and/or Diagnostic Agent/Agents
11/04/2010US20100279861 Antifungal Agents
11/04/2010US20100279407 Alpha 1-acid glycoprotein, alpha 2-hs glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100279333 Methods of treatment with antibodies to a chemokine expressed in inflamed adenoid
11/04/2010US20100279325 Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis
11/04/2010US20100279323 Method for predicting response to epidermal growth factor receptor-directed therapy
11/04/2010US20100278937 Compositions and methods to prevent and/or treat cancer with pa-card
11/04/2010US20100278925 Formulations of organo-platinic compounds in the presence of associative polymers, products thus obtained and uses thereof
11/04/2010US20100278924 Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
11/04/2010US20100278923 Functional nanoparticle-based antibiotics and preparation method thereof
11/04/2010US20100278922 Methods and compositions for oral administration of insulin
11/04/2010US20100278916 Topical application and formulation of erythropoietin for skin wound healing
11/04/2010US20100278907 Immunogenic Compositions Containing Ceramide and Methods of Use Thereof
11/04/2010US20100278895 Antioxidants and antimicrobial accessories including antioxidants
11/04/2010US20100278894 Antioxidants and antimicrobial accessories including antioxidants
11/04/2010US20100278892 High affinity metal-oxide binding peptides with reversible binding
11/04/2010US20100278887 Use of a Haemoglobin for the Preparation of Dressings and Resulting Dressings
11/04/2010US20100278883 Use of amphiphilic self-assembling proteins for formulating poorly water-soluble effect substances
11/04/2010US20100278881 Use of calcitonin in osteoarthritis
11/04/2010US20100278867 Use of botulinum toxin for the treatment of chronic facial pain
11/04/2010US20100278857 Dendritic Cell Binding Proteins and Uses Thereof
11/04/2010US20100278856 BoNT/A PEPTIDES AND METHODSOF PREDICTING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY
11/04/2010US20100278851 Ctl inducer composition
11/04/2010US20100278843 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity
11/04/2010US20100278840 Methods for treating rheumatoid arthritis using il-17 antagonists
11/04/2010US20100278831 Nogo Receptor-Mediated Blockade of Axonal Growth
11/04/2010US20100278830 Methods and systems for multi-antibody therapies
11/04/2010US20100278828 Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases
11/04/2010US20100278827 Concatameric immunoadhesion molecule
11/04/2010US20100278825 Mammalian Receptor Proteins; Related Reagents and Methods
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/04/2010US20100278807 Novel antimicrobial agents
11/04/2010US20100278806 Composition Containing Arazyme for the Prevention and Treatment of Arthritis
11/04/2010US20100278805 Compositions for inhibiting atherosclerosis
11/04/2010US20100278804 Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders
11/04/2010US20100278803 Alzheimer's Disease Diagnosis Based on Mitogen-Activated Protein Kinase Phosphorylation
11/04/2010US20100278802 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
11/04/2010US20100278801 Compositions comprising optimized her1 and her3 multimers and methods of use thereof
11/04/2010US20100278800 Stem cell factor-like proteins and uses thereof
11/04/2010US20100278798 Methods and systems for forming biocompatible materials
11/04/2010US20100278797 Pharmaceutical Composition and Method for Regulating Abnormal Cellular Proliferation
11/04/2010US20100278792 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
11/04/2010US20100278790 Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage
11/04/2010US20100278779 Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
11/04/2010US20100278778 Method for bone marrow preservation or recovery
11/04/2010US20100278777 Method for treating deficiency in hematopoiesis
11/04/2010US20100278776 Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
11/04/2010US20100278775 Plant Bioreactor For The Production Of Interleukin-24 Cytokine
11/04/2010US20100278774 Fusion molecules and il-15 variants
11/04/2010US20100278773 Chimeric flavivirus vaccines
11/04/2010US20100278772 Dna methylation markers and methods of use
11/04/2010US20100278765 Regulation of mammalian keratinous tissue using hexamidine compositions
11/04/2010US20100278759 Topical Therapeutic Delivery System
11/04/2010US20100278756 Peptides having activities of insulin like growth factor-1 and their uses
1 ... 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 ... 3163